An interventional study of Air-Polish and Ultrasonic in Peri-implant Mucositis, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by University of Michigan · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Mucositis with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Mucositis · United States.
Among the 75 studies in Mucositis with a site in United States, this one is the 24th largest by enrollment of the 68 interventional ones that give a count, is one of 2 that started in 2023, is one of 20 with no phase, and was the 72nd registered.
265 studies on the registry are indexed under Mucositis; 34 are open to participants now.
Browse Mucositis studies →3 of the 75 studies in Mucositis with a site in United States are open now. Recruiting first, the newest first:
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18–18 · Healthy volunteers
Matrix Biomed, Inc. · Sites in United States
Ages 18+
Medical College of Wisconsin · Sites in United States
Ages up to 30
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 21 Mucositis studies recruiting now, 13 (62%) set no upper age limit and 7 (33%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 31 · Phase 3 9 · Phase 4 4
First in 1999; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 51 is above the median of 45 across 215 interventional studies indexed under Mucositis.
Median enrollment 33 across the 68 interventional studies, 180 across the 7 observational. Of the 60 that completed or were terminated, 29 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
19 of 75 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 1 study filed under Mucositis — fewer than ten, so there is no comparison to draw.
3 of the studies in Mucositis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05966194EpicentRx, Inc.RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer | 2027-07-01 |
| NCT07053969The University of Texas Health Science Center at San AntonioThe Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness | 2027-09 |
| NCT06623305Medical College of WisconsinA Clinical Trial of the Administration of Light Therapy to Prevent Mouth Sores in Children With Cancer | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 75 studies in Mucositis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators are evaluating the therapeutic outcomes of two cleaning instruments on treating peri-implant mucositis. Peri-implant mucositis is inflammation around an implant that is limited to only the gum tissue and is characterized by bleeding on probing, pus, and without any evidence of bone loss. The investigators wish to compare the amount of inflammation and bacteria through measurements (like probing depth) and by collecting fluid and plaque samples around participants' implant after using one of the two cleaning instruments.
Despite the potential benefits of an air-polishing device with erythritol powder, clinical trials using the device as a monotherapy for treating patients with peri-implant mucositis remained limited. Therefore, the primary aim of the present study is to compare clinical outcomes of the non-surgical treatment of peri-implant mucositis and subsequent supportive peri-implant therapy (SPIT) using an erythritol air-polishing device or conventional mechanical debridement. The secondary aim is to compare the resolution of inflammation after non-surgical treatment of peri-implant mucositis and to monitor levels of peri-implant tissues inflammation during supportive peri-implant therapy by using the level of selected pro-inflammatory cytokines.
Up to 60 participants with dental implants will be recruited from patients seeking and/or receiving dental care at the University of Michigan Graduate Periodontics department, until 34 peri-mucositis participants and 17 healthy participants are achieved.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Must have at least one osseointegrated dental implant with the following conditions (Berglundh et al. 2018a).
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dental implant has peri-implant mucositis
Device: Air-Polish · Device: Ultrasonic
Dental implant does not have peri-implant mucositis
Device: Air-Polish
Dental implant will be cleaned with an airpolishing device
Dental implant will be cleaned with an ultrasonic device with a plastic tip
Probing Depth Measurements
To compare probing depth measurements in millimeters after non-surgical treatment of peri-implant mucositis
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Bleeding on Probing Scores (Mombelli et al.)
To compare bleeding on probing after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating heavier bleeding.
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Plaque Score (Loe & Silness)
To compare plaque scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater plaque accumulation.
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Gingival Index (Loe & Silness)
To compare gingival index scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater inflammation.
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Gum Recession Measurement
To compare gum recession after non-surgical treatment of peri-implant mucositis
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Bone Measurement
Loss of supporting bone measured by standardized radiographs
Time frame: Baseline, 3 months, and 6 months
Interleukin-6 Levels
To compare changes in the concentration of interleukin-6 (IL-6) in peri-implant crevicular fluid (PICF).
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Bacterial DNA Levels
The reported bacterial assessment values are a mix of the entire bacterial load present in the oral cavity. The values in the data table are a composite measure including Aa, Pg, Pi, Tf, and Td. One composite value is reported for each Arm/Group at each time point.
Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
| Milestone | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) | Healthy |
|---|---|---|---|
| Started | 17 | 17 | 17 |
| Completed | 15 | 15 | 15 |
| Not completed | 2 | 2 | 2 |
| Withdrew: Lost to follow-up | 2 | 2 | 2 |
To compare probing depth measurements in millimeters after non-surgical treatment of peri-implant mucositis
| millimeters | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|
| Baseline | 3.14 ± 0.16 | 3.20 ± 0.14 |
| 2 weeks | 2.91 ± 0.19 | 2.97 ± 0.17 |
| 4 weeks | 2.94 ± 0.18 | 2.66 ± 0.17 |
| 3 months | 2.87 ± 0.18 | 2.94 ± 0.17 |
| 6 months | 3.03 ± 0.18 | 3.06 ± 0.17 |
To compare bleeding on probing after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating heavier bleeding.
| score on a scale | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|
| Baseline | 0.522 ± 0.056 | 0.567 ± 0.062 |
| 2 weeks | 0.357 ± 0.073 | 0.411 ± 0.082 |
| 4 weeks | 0.400 ± 0.072 | 0.323 ± 0.082 |
| 3 months | 0.433 ± 0.072 | 0.411 ± 0.082 |
| 6 months | 0.478 ± 0.072 | 0.533 ± 0.083 |
To compare plaque scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater plaque accumulation.
| score on a scale | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|
| Baseline | 0.233 ± 0.087 | 0.256 ± 0.054 |
| 2 weeks | 0.186 ± 0.118 | 0.100 ± 0.073 |
| 4 weeks | 0.178 ± 0.116 | 0.023 ± 0.073 |
| 3 months | 0.100 ± 0.116 | 0.067 ± 0.073 |
| 6 months | 0.189 ± 0.116 | 0.142 ± 0.074 |
To compare gingival index scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater inflammation.
| score on a scale | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|
| Baseline | 0.311 ± 0.043 | 0.311 ± 0.059 |
| 2 weeks | 0.143 ± 0.062 | 0.200 ± 0.070 |
| 4 weeks | 0.089 ± 0.061 | 0.189 ± 0.070 |
| 3 months | 0.067 ± 0.061 | 0.089 ± 0.070 |
| 6 months | 0.056 ± 0.061 | 0.015 ± 0.071 |
To compare gum recession after non-surgical treatment of peri-implant mucositis
| millimeters | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|
| Baseline | 0.33 ± 0.13 | 0.13 ± 0.066 |
| 2 weeks | 0.25 ± 0.55 | 0.13 ± 0.23 |
| 4 weeks | 0.33 ± 0.52 | 0.22 ± 0.25 |
| 3 months | 0.13 ± 0.40 | 0.17 ± 0.31 |
| 6 months | 0.17 ± 0.41 | 0.07 ± 0.18 |
Loss of supporting bone measured by standardized radiographs
No measurements were reported for this outcome.
To compare changes in the concentration of interleukin-6 (IL-6) in peri-implant crevicular fluid (PICF).
| nanograms per milliliter (Ng/ml) | Healthy | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|---|
| Baseline | 192.0 ± 220.2 | 335.2 ± 324.5 | 258.5 ± 260.9 |
| 2 weeks | 264.4 ± 277.0 | 419.1 ± 405.1 | 252.2 ± 172.7 |
| 4 weeks | 192.0 ± 183.5 | 343.7 ± 464.1 | 268.6 ± 156.2 |
| 3 months | 187.4 ± 209.6 | 385.5 ± 333.7 | 352.2 ± 247.1 |
| 6 months | 199.4 ± 215.3 | 395.5 ± 424.5 | 300.9 ± 229.8 |
The reported bacterial assessment values are a mix of the entire bacterial load present in the oral cavity. The values in the data table are a composite measure including Aa, Pg, Pi, Tf, and Td. One composite value is reported for each Arm/Group at each time point.
| nanograms per microliter (ng/ul) | Healthy | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) |
|---|---|---|---|
| Baseline | 12.17 ± 5.42 | 20.33 ± 17.88 | 8.67 ± 3.84 |
| 2 weeks | 9.70 ± 5.93 | 19.49 ± 10.67 | 13.54 ± 13.52 |
| 4 weeks | 12.97 ± 10.52 | 16.85 ± 8.11 | 7.14 ± 3.38 |
| 3 months | 12.25 ± 8.43 | 16.07 ± 11.96 | 18.40 ± 12.61 |
| 6 months | 7.40 ± 4.36 | 19.21 ± 23.87 | 10.99 ± 12.14 |
Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Peri-mucositis (Air Polishing Group) | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| Peri-mucositis (Ultrasonic Group) | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| Healthy | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| Age, Customized(years) | Healthy | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) | Total |
|---|---|---|---|---|
| Mean Age (years) | 58 ± 19 | 58 ± 16 | 67 ± 11 | 61 ± 15.91 |
| Sex: Female, Male(Participants) | Healthy | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) | Total |
|---|---|---|---|---|
| Female | 6 | 3 | 11 | 20 |
| Male | 9 | 12 | 4 | 25 |
| Race and Ethnicity Not Collected(Participants) | Healthy | Peri-mucositis (Air Polishing Group) | Peri-mucositis (Ultrasonic Group) | Total |
|---|---|---|---|---|
| Count of participants | — | — | — | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Oct 2023 to primary completion in Mar 2025, 16 months.
Results were first posted in Oct 2026, 1 year 7 months after primary completion.
Of 67 non-industry interventional studies with no phase under Mucositis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 26. This study's 16 months is above that.
Counting every sponsor, half of 70 studies reached it within 12 months; a quarter within 6 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.